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Abstract 49	  
Introduction: Peroxiredoxin (PRDX) and Thioredoxin (TRX) are antioxidant proteins that 50	  
control cellular signalling and redox balance, although their response to exercise is unknown. 51	  
This study aimed to assess key aspects of the PRDX-TRX redox cycle in response to three 52	  
different modes of exercise. 53	  
Methods: Healthy males (n=10, mean ± SD: age 22 ± 3 yrs) undertook three exercise trials 54	  
on separate days: two steady-state cycling trials at a moderate (60% 2OV! MAX; 27 min, MOD) 55	  
and high (80% 2OV! MAX; 20 min, HIGH) intensity, and a low volume high intensity interval 56	  
training trial (10×1 min 90% 2OV! MAX, LV-HIIT). Peripheral blood mononuclear cells 57	  
(PBMCs) were assessed for TRX-1 and over-oxidised PRDX (isoforms I-IV) protein 58	  
expression before, during and 30 minutes following exercise (post+30). The activities of 59	  
TRX reductase (TRX-R) and the NF-κB p65 subunit were also assessed. 60	  
Results: TRX-1 increased during exercise in all trials (MOD +84.5%; HIGH +64.1%; LV-61	  
HIIT +205.7%; p<.05), whereas over-oxidised PRDX increased during HIGH only (MOD -62	  
28.7%; HIGH +202.9%; LV-HIIT -22.7%; p<.05). TRX-R and NF-κB p65 activity increased 63	  
during exercise in all trials, with the greatest response in TRX-R activity seen in HIGH 64	  
(p<.05). 65	  
Discussion: All trials stimulated a transient increase in TRX-1 protein expression during 66	  
exercise. Only HIGH induced a transient over-oxidation of PRDX, alongside the greatest 67	  
change in TRX-R activity. Future studies are needed to clarify the significance of heightened 68	  
peroxide exposure during continuous high intensity exercise and the mechanisms of PRDX-69	  
regulatory control.70	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Introduction 71	  
Exercise induces the production of reactive oxygen and nitrogen species (RONS), which 72	  
act as important signalling molecules in the vast array of metabolic adaptations that take 73	  
place in human tissues [1,2]. However, exercise of a certain intensity and duration can induce 74	  
acute cellular oxidative stress, a state whereby RONS overwhelm endogenous antioxidant 75	  
defence systems [3,4]. The exercise conditions required to achieve an optimal production of 76	  
RONS in order to stimulate adaptive processes, versus RONS that may initiate damage, is 77	  
currently unknown. Changes in markers of oxidative stress with exercise are commonly 78	  
studied in cells of the immune system, such as peripheral blood mononuclear cells (PBMCs) 79	  
[4,5] and recent work has focussed on the antioxidant proteins peroxiredoxin (PRDX) [6] and 80	  
thioredoxin (TRX) [7]. PRDX and TRX are ubiquitous oxidoreductase proteins that contain 81	  
thiol groups with a high capacity to control cellular levels of RONS and reduce oxidative 82	  
stress [8,9]. PRDX can directly target and reduce biological peroxides such as hydrogen 83	  
peroxide (H2O2), peroxynitrite and hydroperoxides [9]. TRX is central in maintaining the 84	  
reduced state of various antioxidant peroxidase enzymes [10], including four isoforms (I-IV) 85	  
of PRDX [11,12]. There is strong evidence that PRDX and TRX are central in modulating 86	  
peroxide based signals within a variety of cell types [13]. Understanding how PRDX and 87	  
TRX regulate the levels of RONS may be essential in aiding understanding of exercise-88	  
induced changes in RONS. 89	  
The oxidation states of TRX and PRDX have been studied extensively to facilitate the 90	  
understanding of cellular signalling in health and disease. The catalytic cysteine of 91	  
monomeric PRDX (20-30 kDa) can become oxidised by a peroxidase substrate to form 92	  
sulfenic acid (-SOH), before rapidly reacting with an adjacent PRDX molecule to form a 93	  
dimeric structure (Figure 1). TRX is the predominant antioxidant that reverses PRDX 94	  
(isoforms I-IV) oxidation and dimer formation [11,14], by similarly utilising its catalytic 95	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cysteine. TRX is subsequently maintained in a reduced state by the Nicotinamide adenine 96	  
dinucleotide phosphate (NADPH) dependent enzyme TRX-reductase (TRX-R). Under 97	  
conditions of high or prolonged peroxide exposure, PRDX has the capacity to become over–98	  
oxidised [15], and exceed the regulatory control of TRX [16]. Over-oxidation of PRDX 99	  
forms sulfinic (-SO2) and sulfonic acid (-SO3) PRDX oxidation states (PRDX-SO2-3) that 100	  
have limited or no peroxidase activity respectively [17]. 101	  
Previous work has highlighted that exercise can enhance the degree of PRDX over-102	  
oxidation (I-IV) in erythrocytes [18]. Only one study has previously addressed exercise-103	  
induced changes to PBMC PRDX oxidation states in humans. Turner et al, [6] observed an 104	  
increase in PRDX over-oxidation following an ultra-endurance race (126.7 - 233.4km; 20.4 - 105	  
41.4 hours of continuous running) in middle aged men. The role of TRX in this redox cycle 106	  
has not been previously monitored in response to exercise. The only study that has assessed 107	  
TRX in humans reported an increase in plasma TRX in response to an ultra-endurance race 108	  
[19]. The dissociation of TRX from TRX-interacting protein (TXNIP) and transcriptional 109	  
activation of TRX via NF-κB are likely mechanisms governing this observed extracellular 110	  
secretion. Indeed, RONS have been shown to upregulate the expression of a variety of 111	  
antioxidant enzymes via increased NF-κB activity [20] and TRX can dissociate from TXNIP 112	  
in a RONS-dependent manner [21]. 113	  
To our knowledge no studies have monitored the over-oxidation of PBMC PRDX 114	  
isoforms (I-IV) and their associations with TRX in response to modes of exercise that are 115	  
more commonly undertaken (i.e. <30 minutes). Further, no studies have examined the impact 116	  
of exercise intensity on these redox processes. The aim of the present study was to investigate 117	  
perturbations to TRX-1 protein expression, TRX reductase activity and PRDX over-oxidation 118	  
in PBMCs in response to three short duration exercise trials. To observe the mechanism of 119	  
TRX-1 response, we also assessed changes in the activity of the p65 subunit of NF-κB. 120	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Material and Methods 121	  
Participants 122	  
 Ten healthy males (Table 1) undertook three exercise trials, each separated by at least 123	  
seven days (Supplementary Figure 1). All participants gave their informed written consent 124	  
and the study was approved by the Science, Technology, Engineering and Mathematics 125	  
Ethical Review Committee at University of Birmingham (Approval number: ERN_12-0830). 126	  
Participants were non-smokers and had not taken any vitamin supplements or anti-127	  
inflammatory drugs for fourteen days prior to the first laboratory visit. Participants were also 128	  
required to refrain from any strenuous physical activity, consumption of alcoholic beverages 129	  
or food or drink with high nitrate content (beetroot, lettuce, spinach and processed meats) for 130	  
at least two days prior to each experimental session. 131	  
 132	  
Preliminary Assessments 133	  
 All experimental sessions took place within the School of Sport, Exercise and 134	  
Rehabilitation Sciences at the University of Birmingham. Participants visited the laboratory 135	  
to complete questionnaires addressing health history and demographics, and to have height 136	  
and weight assessed (Seca Alpha, Hamburg, Germany). Cardiorespiratory fitness ( 2OV! MAX) 137	  
was measured using an incremental test to exhaustion on an electromagnetically braked cycle 138	  
ergometer (Lode Excalibur Sport, Groningen, Netherlands). Following a three-minute warm 139	  
up at 30 watts, workload was increased by 30 watts every minute, until volitional exhaustion. 140	  
Oxygen uptake was assessed continuously using a breath-by-breath system (Oxygon Prx, 141	  
Jaeger, Wuerzberg, Germany) and heart rate monitored using a Polar Vantage heart rate 142	  
monitor (Polar Vantage, Kempele, Finland). The following criteria were used to indicate that 143	  
2OV! MAX had been reached: a fall in cadence below 60rpm, a respiratory exchange ratio 144	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( 2COV! / 2OV! ) >1.10-1.15, plateau in participant oxygen consumption or a maximal heart 145	  
rate >220 beats min-1- age [22]. 2OV! MAX was expressed relative to body weight (ml.kg-1min-146	  
1). 147	  
 148	  
Exercise Trials 149	  
 Seven days after preliminary measurements, participants returned to the laboratory to 150	  
undertake the first of three exercise trials. All trials were undertaken in the morning, 151	  
following an overnight fast, and all participants performed the three trials in a randomised 152	  
design. Each trial was separated by at least three days. Prior to each exercise trial, participants 153	  
undertook a warm up (5 minutes) at a workload eliciting 40% 2OV! MAX. Exercise trials were: 154	  
two workload matched steady-state cycling trials at moderate (60% 2OV! MAX; 27 minutes, 155	  
MOD) and high (80% 2OV! MAX; 20 minutes, HIGH) intensity and a low volume high 156	  
intensity interval training (LV-HIIT) trial. LV-HIIT consisted of ten 1 minute cycling 157	  
intervals at 90% 2OV! MAX, with 1 minute low intensity cycling at 40% 2OV! MAX.  158	  
 159	  
 160	  
Blood sampling 161	  
Prior to exercise, a catheter (Becton, Dickson & Company, Oxford, UK) was inserted 162	  
into the antecubital vein of the arm and a rested blood sample drawn after thirty minutes of 163	  
supine rest (baseline). The catheter was kept patent with saline (0.9% NaCl). Subsequent 164	  
blood samples were taken during the last minute of exercise (exercise) and then 30 minutes 165	  
following the exercise trial (post+30). At each time point, 15 ml of blood was drawn into four 166	  
separate vacutainer tubes containing potassium ethylene diaminetetraacetic acid (EDTA) 167	  
(Becton, Dickson & Company, Oxford, UK). 168	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 169	  
Blood Cell Isolation 170	  
Three EDTA tubes (approximately 15 ml) from each time point were used to isolate 171	  
PBMCs from whole blood using density gradient centrifugation. Briefly, whole blood was 172	  
diluted 1:1 with Roswell Park Memorial Institute Media (RMPI), and then layered carefully 173	  
on top of Ficoll paque PLUS (GE Healthcare) (2:1), before centrifuging at 400g for 30 174	  
minutes at 21°C.  The PBMC layer was aspirated and then washed three times with RPMI, by 175	  
centrifuging steps at 200g for 5 minutes. The final cell pellet was divided into two equal 176	  
aliquots. The first aliquot was lysed using RIPA buffer (1x, Sigma Aldrich) containing a 177	  
protease inhibitor cocktail (1µL/mL, Sigma Aldrich), vortexed thoroughly and lysate 178	  
collected. The second aliquot was resuspended in a freezing mixture (RPMI, fetal calf serum 179	  
(FCS) and dimethyl sulfoxide (DMSO); 7:2:1) and frozen at −1°C /min using a freezing 180	  
container (Nalgene “Mr Frosty” Thermoscientific). Both aliquots were stored at -80°C until 181	  
further analyses. 182	  
 183	  
Analytical Procedures 184	  
 Whole blood cell counts (i.e., total leukocyte differential) were assessed using the 185	  
coulter principle. In addition, haemoglobin (g/dL) and haematocrit (%) were assessed to 186	  
calculate blood volume changes as a result of exercise using the formulae shown in Bosch et 187	  
al, 2005 [23,24] (Coulter Analyser, Beckman-Coulter, High Wycombe, UK). Protein 188	  
concentration was determined using the bicinchoninic assay method [25]. 189	  
 190	  
Western Blotting Protocol 191	  
All reagent mixtures were sonicated thoroughly prior to use. PBMC protein lysates 192	  
(10 µg) were mixed 1:1 with laemmli sample buffer (10% 2-mercaptoethanol, Sigma Aldrich, 193	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Dorset, UK) and separated on 15-18% polyacrylamide gels. Gels were electrophoresed at 194	  
115V for 105 minutes using electrophoresis buffer (25 mM Tris, 192 mM glycine, and 0.1% 195	  
w/v SDS). Proteins were transferred onto Hybond-P® PVDF membrane (GE Healthcare, 196	  
Amersham, UK) with transfer buffer (25 mM Tris, 192 mM glycine, and 20% w/v methanol) 197	  
for 105 minutes at 170mA. Transfer was assessed by Ponceau S (Sigma Aldrich, Dorset, UK) 198	  
before membranes were washed with sodium hydroxide (0.1 M) and then blocked overnight 199	  
in non-fat milk (5%) in TBST blocking buffer (0.21 M NaCl, 0.05 M Tris Base, 0.1% w/v 200	  
Tween). Membranes were washed 6 times (5 minutes) in TBST (0.21 M NaCl, 0.05 M Tris 201	  
Base, 0.05% w/v tween-20) prior to incubation with rabbit polyclonal for anti-PRDX-SO2-3 202	  
(I-IV) (1:500, ab16830, Abcam, Cambridge, UK), mouse monoclonal anti-TRX-1 (1:1000, 203	  
ab16965, Abcam, Cambridge, UK), and mouse monoclonal anti-beta actin (1:10,000, A1978, 204	  
Sigma Aldrich, Dorset, UK) antibodies for 2 hours at room temperature. Membranes were 205	  
washed (6x5 min) before peroxidase conjugated goat anti-rabbit (for PRDX SO2-3 (I-IV) work, 206	  
1:10,000, A6154) or goat anti-mouse (for TRX-1 and beta actin work, 1:10,000, A0168) 207	  
antibodies (Sigma Aldrich, Dorset, UK) were applied for 1 hour at room temperature. 208	  
Following a further washing step (6 x 5 min), visualisation of proteins was undertaken using 209	  
Amersham ECL Prime detection reagent (GE Healthcare, Amersham, UK). Imaging and 210	  
band quantification was assessed using Syngene G:Box F3 (Geneflow, Staffordshire, UK) and 211	  
Syngene tools software respectively, and expressed in arbitrary units. 212	  
 213	  
Thioredoxin Reductase Activity 214	  
PBMCs were rapidly thawed in a water bath (37°C). Pellets were washed twice in 215	  
RPMI and FCS (9:1) to discard excess DMSO. Approximately 2 million cells were counted 216	  
using a haemocytometer and aliquoted for each time point (baseline and exercise). All 217	  
samples were adjusted to the lowest sample protein concentration. The lysate was then 218	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assessed for TRX reductase enzyme activity using a commercially available kit according to 219	  
manufacturer instructions (ab83463, Abcam, Cambridge, UK). Briefly, assay buffer (10 µl) or 220	  
TRX reductase inhibitor (10 µl) were added to two sets of identical samples (50 µl, diluted to 221	  
0.55mg/ml protein using assay buffer). All samples were then incubated with a reaction mix 222	  
(30µl assay buffer + 8µl 5,5’-dithiobis (2-nitrobenzoic) acid (DTNB) + 2µl nicotinamide 223	  
adenine dinucleotide phosphate (NADH) per well) and absorbances (λ = 412 nm) determined 224	  
immediately and at 25 minutes to monitor reaction kinetics (Labsystems Multiskan MS, 225	  
Virginia, USA). Values were then obtained from a linear standard curve of known 5-thio-2-226	  
nitrobenzoic acid (TNB) concentrations (0-50 nmol/well). 227	  
 228	  
NF- κB p65 subunit activation 229	  
The activity of the p65 subunit of NF-κB was assessed using a commercially available 230	  
ELISA (TransAM NF-kB p65 Chemi, Active Motif, La Hulpe, Belgium). Briefly, PBMC 231	  
lysates (6µg/well) were added to wells coated with an oligonucleotide, containing the NF-κB 232	  
consensus site (5’-GGGACTTTCC-3’). An antibody specific to an epitope on the p65 subunit 233	  
of NF-κB (50µl, 1:1000) was added to each sample, with binding occurring only when NF-234	  
kB was activated and bound to the target DNA sequence. Data are expressed as relative 235	  
absorbance units (nm). 236	  
 237	  
Statistical Analysis 238	  
 The Kolmogorov Smirnov test was used to test for normally distributed data at all 239	  
time points. Normally distributed variables (changes in lymphocytes, monocytes, lymphocyte: 240	  
monocyte ratio and, NF-kB activity and TRX-R activity) in response to exercise were 241	  
assessed by repeated measures ANOVA. All white blood cell values were adjusted for 242	  
changes in blood volume in response to exercise. Post hoc analysis of any interaction effects 243	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was performed by a test of simple effects by pairwise comparisons, with Bonferroni 244	  
correction. Non-normally distributed data (TRX-1 and PRDX-SO3 protein expression 245	  
changes) in response to exercise were analysed using the Friedman’s test, with Wilcoxon 246	  
signed-ranked pairwise comparisons. Differences between variables (e.g., participant 247	  
characteristics) at baseline were assessed using one-way analyses of variance (ANOVA). 248	  
Values are presented as means ± standard deviation or error (indicated throughout 249	  
manuscript). Statistical significance was accepted at the p<.05 level. Statistical analyses were 250	  
performed using SPSS (PASW Statistics, release 21.0, SPSS Inc., Chicago, IL, USA).   251	  
 252	  
Results 253	  
Participant characteristics 254	  
All participant characteristics are summarised in table 1. None of the participants 255	  
were smokers, nor taking regular medications or antioxidant supplements. 256	  
 257	  
Exercise Physiology Data 258	  
Table 2 reports the exercise physiology data during the three exercise trials. Total 259	  
energy expenditure (Kcal/ kg) was significantly lower in LV-HIIT, compared to HIGH 260	  
(p<0.0001) and MOD (p<0.0001) trials. There were no statistical differences in energy 261	  
expenditure between MOD and HIGH. Peak heart rate and rate of perceived exertion was 262	  
greatest during HIGH, relative to MOD (p’s<0.0001) and LV-HIIT (p’s<0.05). Peak heart 263	  
rate was significantly greater in HIGH compared to LV-HIIT (p=0.025). 264	  
 265	  
White Blood Cell Data 266	  
 Table 3 reports the changes in lymphocyte number, monocyte number and 267	  
lymphocyte: monocyte ratio, adjusted for changes in blood volume in response to the three 268	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exercise trials. Lymphocyte number increased during exercise in all trials (F2,18 = 54.3, 269	  
p<0.0001) and returned to baseline post+30 (F2,18 = 54.3, p<.0001). A significant time × 270	  
condition interaction was observed (F4,36 = 18.5, p<.0001) and pairwise comparisons revealed 271	  
that the increase in lymphocyte number during HIGH was greater than MOD (p=0.002). 272	  
Monocyte number increased during exercise in all trials (p=0.028) and returned to baseline 273	  
levels post+30 (p=.010). No differences were observed in monocyte number between trials. 274	  
No statistical differences were observed in lymphocyte: monocyte ratio in response to any of 275	  
the exercise trials.  276	  
 277	  
Thioredoxin-1 and Peroxiredoxin-SO2-3 (I-IV) protein expression changes 278	  
Figures 2 and 3 indicate changes in TRX-1 and PRDX SO2-3 (I-IV) expression in the 279	  
three exercise trials following normalisation for beta-actin and quantification with Genetools 280	  
(arbitrary values). Figures 2B and 3B are example western blots for one participant. TRX-1 281	  
increased in response to exercise in MOD (Ӽ2 (2) = 8.600, p=0.014), HIGH (Ӽ2 (2) = 6.200, 282	  
p=0.045) and LV-HIIT (Ӽ2 (2) = 11.436, p=0.003). Post hoc analyses with Wilcoxon signed-283	  
rank tests revealed a significant increase in TRX-1 from baseline to during exercise in the 284	  
LV-HIIT trial only (Z = -2.666, p=0.008). However, no differences were observed in TRX-1 285	  
protein expression during exercise between the three trials, i.e. increases in TRX-1 were not 286	  
exercise intensity dependent. Total PRDX-SO2-3 increased in response to HIGH only (Ӽ2 (2) 287	  
= 7.824, p=0.020). Post hoc analyses revealed that PRDX- SO2-3 increased during HIGH, 288	  
relative to baseline (Z = -2.524, p=.012). 289	  
	   290	  
Thioredoxin Reductase Activity 291	  
Figure 4 indicates changes in TRX reductase activity from baseline to during exercise 292	  
in the three exercise trials. TRX reductase activity increased during exercise, relative to 293	  
13	  
	  
baseline in all trials (F1,9 = 82.7, p=.002). A significant group x time interaction effect was 294	  
found (p=0.010), and a test of simple effects analysis by pairwise comparisons indicated that 295	  
the change in TRX reductase enzyme activity during exercise was greater in HIGH than 296	  
MOD (F2,18 = 3.1, p=.042). Differences between HIGH and LV-HIIT did not reach statistical 297	  
significance (p=.123). TRX reductase activity values returned to baseline post+30 (data not 298	  
shown). 299	  
 300	  
NF- κB p65 subunit activation 301	  
Figure 5 indicates changes in NF-kB p65 subunit activation in response to exercise. 302	  
NF-kB p65 activity increased during exercise in all trials, relative to baseline (F2,18 = 4.0, p = 303	  
0.036). No differences were observed between trials. 304	  
 305	  
Discussion 306	  
This study demonstrates that PBMC TRX-1 protein expression and NF-kB p65 activity 307	  
increased during exercise in young healthy males, irrespective of exercise intensity. An 308	  
increase in over-oxidised PRDX was shown during exercise in HIGH only. The activity of 309	  
TRX-R increased during exercise in all trials, with the greatest response observed in HIGH. 310	  
To our knowledge this is the first study assessing changes in PBMC TRX-1 protein 311	  
expression in response to single bouts of exercise in humans (Figure 2). Previously, TRX-1 312	  
protein expression in PBMCs of mice significantly increased 12 hours following a short bout 313	  
of swimming exercise, with no changes observed between 30 minutes and 6 hours [7]. In 314	  
response to heightened oxidative stress, TRX can scavenge RONS [12], reduce oxidised 315	  
macromolecules [10] and regulate the expression/recycling of antioxidant proteins such as 316	  
manganese superoxide dismutase [26] and reduced glutathione [27]. The transient changes in 317	  
14	  
	  
both TRX-1 expression and NF-kB p65 activity (i.e. increase during exercise and return to 318	  
baseline values within thirty minutes), suggests that cytosolic TRX-1 has been released in a 319	  
RONS-dependent manner from its binding protein Thioredoxin-interacting protein (TXNIP) 320	  
[21] to elicit an array of antioxidant actions during all exercise trials. NF-kB activity has been 321	  
shown to be increased in response to various modes of exercise [28,29] and to elicit a variety 322	  
of antioxidant actions [20,30]. Hollander et al, showed that superoxide dismutase expression 323	  
increased in response to aerobic exercise in the vastus lateralis muscle of rats, with maximal 324	  
NF-kB binding occurring at 2 and 10 hours post-exercise [30]. The transient activation of 325	  
NF-kB in the current study could be, in part, due to direct TRX binding of NF-kB [8]. We 326	  
suggest that thirty minutes following cessation of exercise, TRX and TXNIP have re-327	  
associated (i.e. reformation of disulphide bond), with transcriptionally regulated changes in 328	  
TRX protein expression occurring later, supporting previous work by Sumida et al, [7]. These 329	  
responses are in agreement with other data from our study confirming transient exercise-330	  
induced increases in whole-body oxidative stress (e.g., increased plasma lipid hydroperoxides 331	  
and elevated plasma total antioxidant capacity) (data not shown; Wadley et al, 2014, 332	  
manuscript under review). It is however surprising that PRDX over-oxidation returned to 333	  
baseline values within thirty minutes of exercise in all trials (Figure 3). Recycling of over-334	  
oxidised PRDX is a process known to occur very slowly in vitro [31]. Despite there being 335	  
limited data on this mechanism in exercising humans, this finding warrants further study.  336	  
Increases in PRDX over-oxidation in PBMCs during exercise may occur in response to 337	  
higher levels of RONS such as H2O2 and peroxynitrite [32]. The catalytic cysteine residue of 338	  
PRDX can utilise its peroxidase activity to regulate peroxide mediated cellular signalling 339	  
[9,33]. In the current study, a significant increase in over-oxidised PRDX (isoforms I – III, 340	  
Figure 3) was only observed during exercise in HIGH, suggesting that peroxide exposure was 341	  
highest in this trial and/or that the reducing power of TRX was sufficient in the other trials to 342	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limit PRDX peroxidase activity. Lower exercise-induced peroxide exposure in MOD and LV-343	  
HIIT may have limited PRDX cysteine oxidation to the initial oxidation state, -SOH. In this 344	  
conformational change, a PRDX cysteine residue forms a disulphide bond with an adjacent 345	  
PRDX molecule [14]. TRX-R, the reducing partner of TRX, showed an increase in activity 346	  
during all exercise trials (Figure 4), with the greatest increase observed during HIGH. This 347	  
too suggests higher peroxide exposure and greater formation of intra-molecular disulphides 348	  
within the TRX protein in HIGH. Collectively, these results suggest that a threshold may 349	  
exist, whereby exercise-induced RONS exposure can exceed TRX/TRX-R regulatory control 350	  
and over-oxidise PRDX. This threshold may have been exceeded during short-duration, high 351	  
intensity steady state exercise.  352	  
Both TRX [34] and PRDX [35] have been previously associated with heightened 353	  
inflammation. Additional data (Wadley et al, 2014, manuscript under review) from this study 354	  
demonstrated that plasma Interleukin (IL)-6 and IL-10 concentrations were significantly 355	  
increased in response to exercise, with the greatest responses observed following HIGH and 356	  
LV-HIIT. Recent evidence has demonstrated that following TRX-TXNIP dissociation, 357	  
TXNIP can directly induce increases in IL-1β, an early inflammatory cascade cytokine [21] 358	  
and signal for IL-6 production [36]. Similarly, PRDX has been linked with IL-23 [35] and IL-359	  
6 production in macrophages [37], primarily following oxidation-induced oligomerisation 360	  
and switch from peroxidase to chaperone function [37]. Further research is necessary to 361	  
understand the interactions and relationships between the redox cycle of PBMCs and the 362	  
inflammatory response/immune cell function.  363	  
It must be noted that despite normalisation of PRDX and TRX data for total cell and 364	  
protein content, shifts in the number and phenotype of lymphocytes and monocytes can occur 365	  
during exercise [5,38]. Indeed, lymphocyte and monocyte number did increase in response to 366	  
exercise in all trials (Table 3). However, previous work has indicated that shifts in the cellular 367	  
16	  
	  
composition of peripheral blood do not influence biomarkers of oxidative stress [3]. A 368	  
limitation to the current study is that PRDX (I-III) protein expression was not measured to 369	  
quantify the relative oxidised to reduced ratio of PRDX proteins. With regards to exercise-370	  
induced changes in PBMC TRX protein expression, future work should expand upon the 371	  
current findings, by distinguishing between TXNIP-mediated and transcriptional regulation 372	  
of TRX by monitoring time-course responses to exercise of various intensities. 373	  
In conclusion, the present results show that both TRX-1 and PRDX are perturbed in 374	  
response to exercise in PBMCs from untrained males. While similar increases in TRX-1 were 375	  
observed in response to all exercise trials, only high intensity steady state exercise (i.e., 376	  
HIGH) caused over-oxidation of PRDX. Future studies should expand upon this work to 377	  
elucidate the implications of PRDX over-oxidation in response to high intensity steady state 378	  
exercise. 379	  
 380	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Tables 514	  
Table 1:  Characteristics of male subjects.   515	  
 
(N=10, male) 
Age (yrs.) 22 ± 3 
Weight (kg) 78.1 ± 11.0 
Height (m) 1.8 ± 0.1 
BMI (kg.m
2
) 24.0 ± 3.1 
VO2max (ml.kg.min
-1
) 42.7 ± 5.0 
 516	  
Table 1 Legend: Values are means ± standard deviation.  517	  
 518	  
 519	  
 520	  
 521	  
 522	  
 523	  
 524	  
 525	  
 526	  
 527	  
 528	  
 529	  
 530	  
 531	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Table 2:  Exercise Physiology Data.  532	  
 MOD HIGH LV-HIIT 
Average Workload 
(Watts / kg) 1.40 ±  0.22 +++ 2.14 ± 0.33 ***+ 2.69 ±  0.54 *** 
Peak Heart Rate 
(bpm) 146.70 ± 11.08 +++ 185.00 ± 9.17 ***+ 176.00 ± 13.80 *** 
Total Energy 
Expenditure (Kcal / 
kg) 
3.33 ± 0.43 3.39 ± 0.47 +++ 2.63 ± 0.34 *** 
Peak rate of 
Perceived Exertion 
(Borg Scale) 
13.33 ± 1.42 17.90 ± 1.45 *** 16.20 ± 2.15 * 
 533	  
Table 2 Legend: Average workload (Watts/kg), peak heart rate (bpm), total energy 534	  
expenditure (Kcal/kg) and peak rate of perceived exertion during the exercise trials. Values 535	  
are means ± standard deviation. * indicates a significant difference in values, relative to 536	  
MOD: * p<.05; ** p<.01; *** p<.0001). + indicates a significant difference in values, 537	  
relative to LV-HIIT: + p<.05; ++ p<.01; +++ p<.0001). 538	  
 539	  
 540	  
 541	  
 542	  
 543	  
 544	  
 545	  
 546	  
 547	  
 548	  
 549	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Table 3:  Immune cell responses to the three exercise trials.  550	  
 551	  
Table 3 Legend:  Lymphocyte, Monocyte and Lymphocyte: Monocyte Ratio data, adjusted 552	  
for changes in blood volume in response to exercise in the MOD, HIGH and LV-HIIT trials. 553	  
Values are means ± standard deviation. * indicates a significant difference relative to baseline: 554	  
* p<.05; ** p<.01; *** p<.0001). $ indicates a significant difference relative to during 555	  
exercise: $ p<.05; $$ p<.01; $$$ p<.0001). # indicates a significantly greater response during 556	  
HIGH relative to MOD (p<.002). 557	  
 558	  
 559	  
 560	  
 561	  
 562	  
 563	  
 564	  
 565	  
 566	  
 567	  
 
MOD HIGH LV-HIIT 
Base Exercise Post+30 Base Exercise Post+30 Base Exercise Post+30 
Lymphocytes 
(×10
6
/ml) 
1.89 ± 
0.47 
2.52 ± 
0.73*** 
1.67 ± 
0.39
$$$
 
1.86 ± 
0.42 
4.27 ± 
1.26***## 
1.79 ± 
0.40
$$$
 
1.79 ± 
0.47 
3.28 ± 
1.31*** 
1.61 ± 
0.40
$$$
 
Monocytes 
(×10
6
/ml) 
0.29 ± 
0.15 
0.41 ± 
0.21* 
0.22 ± 
0.08
$$
 
0.32 ± 
0.18 
0.56 ± 
0.39* 
0.31 ± 
0.14
$$
 
0.23 ± 
0.11 
0.37 ± 
0.10* 
0.33 ± 
0.16
$$
 
Lymphocyte: 
Monocyte 
Ratio 
7.60 ± 
3.04 
7.19 ± 
4.71 
8.54 ± 
3.45 
7.44 ± 
3.58 8.86 ± 4.55 
6.79 ± 
3.12 
10.02 
± 6.50 
9.47 ± 
5.74 
5.64 ± 
2.09 
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Figure Legends 568	  
Figure 1:  A schematic representation of the oxidation states of PRDX and TRX 569	  
following peroxide exposure. R = R-group -SH = Sulfhydryl group  SRX = Sulfiredoxin  S-570	  
S = Disulphide Bond 571	  
 572	  
Figure 2:  Total TRX-1 levels in response to the three exercise trials. A) Bars represent 573	  
total TRX-1 in PBMC lysates before (Baseline), during (Exercise) and thirty minutes 574	  
following exercise (Post+30). Values are means ± standard error. * indicates significant 575	  
differences during exercise, relative to baseline: * p<.05; ** p<.01; *** p<.0001). B) 576	  
Example western blot of a single subject. The image represents PBMC lysates under reducing 577	  
conditions.	  578	  
 579	  
Figure 3:  Total PRDX-SO2-3 (I-IV) levels in response to the three exercise trials. A) Bars 580	  
represent total PRDX-SO2-3 (I-IV)  in PBMC lysates before (Baseline), during (Exercise) and 581	  
thirty minutes following exercise (Post+30). Values are means ± standard error. * indicates 582	  
significant differences during exercise, relative to baseline: * p<.05; ** p<.01; *** p<.0001). 583	  
B) Example western blot of a single subject. The image represents PBMC lysates under 584	  
reducing conditions. The two distinct bands in are representative of the different isoforms of 585	  
PRDX. Over-oxidised PRDX isoforms 1 and 2 resolve at 20-22kDa, PRDX-3 at 26kDa and 586	  
PRDX-4 at 31kDa (no band). 587	  
 588	  
Figure 4:  Changes in Thioredoxin Reductase Activity during exercise, relative to 589	  
baseline in response to the three exercise trials. Bars represent changes in Thioredoxin 590	  
Reductase Activity in PBMC lysates from baseline to during exercise. Values are means ± 591	  
25	  
	  
standard error. * indicates significant differences in response to exercise, relative to baseline 592	  
in all trials: * p<.05; ** p<.01; *** p<.0001). # indicates a significant difference in the 593	  
response between HIGH and MOD during exercise (p<0.042). Enzyme activity was also 594	  
assessed 30 minutes post-exercise and values returned to baseline levels (data not shown). 595	  
 596	  
Figure 5:  Changes in NF-κB	  p65 subunit activation in response to the three exercise 597	  
trials. Bars represent relative absorbance values in PBMC lysates before (Baseline), during 598	  
(Exercise) and thirty minutes following exercise (Post+30). Values are means ± standard 599	  
error. * indicates significant differences during exercise, relative to baseline: * p<.05; ** 600	  
p<.01; *** p<.0001). 601	  
 602	  
Supplementary Figure 1:  Experimental protocol. Participants completed 3 randomised 603	  
exercise trials in a fasted state.  LV-HIIT consisted of ten 1 minute stages at 90% 2OV! MAX, 604	  
interspersed with nine 1 minute intervals at 40% 2OV! MAX.  605	  
↓ Blood samples (baseline, exercise & post+30);   W, Warm up 606	  
	  607	  
 608	  
 609	  
 610	  
 611	  
 612	  
 613	  
 614	  
 615	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Supplementary Table 616	  
 617	  
Supplementary Table 1:  Changes in blood and plasma volume in response to exercise.  618	  
 619	  
 MOD HIGH LV-HIIT 
Base Exercise Post+30 Base Exercise Post+30 Base Exercise Post+30 
Blood 
Volume 
(%) 
100 94.2 ± 
4.7*** 
99.9 ± 
5.0$$$ 
100 92.3 ± 
2.9 *** 
100.7 ± 
4.5$$$ 
100 91.8 ± 
4.2*** 
99.3 ± 
4.2$$$ 
Plasma 
Volume 
(%) 
57.6± 
2.7 
55.8 ± 
12.7** 
57.5 
± 3.8$$ 
56.4 
± 3.7 
48.2 ± 
3.5** 
56.9 
± 3.8$$ 
57.7 
± 2.3 
49.3 ± 
4.2** 
56.7 ± 
4.4$$ 
 620	  
Supplementary Table 1 Legend:  Changes in blood volume, relative to baseline (100) are 621	  
indicated. Plasma volume was calculated by monitoring changes in blood haematocrit. 622	  
Values are means ± standard error. * indicates significant differences in response to exercise, 623	  
relative to baseline in all trials: * p<.05; ** p<.01; *** p<.0001). $ indicates a significant 624	  
difference relative to during exercise: $ p<.05; $$ p<.01; $$$ p<.0001).	  625	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